ArticleJournal of medical systems2025
Artificial Intelligence-Enabled Electrocardiography Identifies Osteoporosis and has Prognostic Value.
Article in Journal of medical systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: Osteoporosis, a common disease leading to weakened bones and increased fracture risk, often goes undiagnosed until a fracture occurs. Dual-energy X-ray absorptiometry (DXA) is the current gold standard for bone mineral density (BMD) measurement, but it has limitations. Recent studies reported Artificial Intelligence (AI)-enabled Electrocardiography (ECG) for disease screening. We hypothesized that AI ECG could serve as a screening tool for osteoporosis. Objective: This study aimed to develop a deep learning model (DLM) to identify osteoporosis using EKG features and to assess its performance and clinical implications. Methods: We conducted a retrospective study involving 25,401 patients who underwent 44,732 EKGs with DXA-measured BMD at two hospitals. The area under the receiver operating characteristic curve (AUC) was used for evaluation. Additionally, our DLM was tested for predicting mortality using Kaplan-Meier survival analysis and the Cox proportional hazards model. Results: The DLM achieved an AUC of 0.741 in internal validation and 0.868 in external validation for detecting osteoporosis. Furthermore, the negative predictive value for osteoporosis was 93.7% in the internal set and 85.8% in the external set. The DLM-detected osteoporosis group exhibited a higher risk of all-cause mortality with a hazard ratio (HR) of 2.06 (95% CI: 1.23–3.45) in the internal validation set, and similar results were observed in the external validation set (HR: 1.87, 95% CI: 1.21–2.89). Conclusion: Our DLM, utilizing EKG for osteoporosis identification, demonstrated impressive results. It has the potential to serve as a cost-effective and practical screening tool for early osteoporosis detection, with significant prognostic implications.
Indexed as
Identifiers
41452504What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.